Vicarious Surgical (NYSE:RBOT) Given New $8.50 Price Target at Piper Sandler

Vicarious Surgical (NYSE:RBOT) had its target price dropped by research analysts at Piper Sandler from $10.50 to $8.50 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s target price would suggest a potential upside of 5.52% from the stock’s previous close.

Vicarious Surgical Price Performance

NYSE RBOT opened at $8.06 on Tuesday. The company has a market cap of $47.59 million, a PE ratio of -0.78 and a beta of 1.35. The stock’s 50 day simple moving average is $12.43 and its 200-day simple moving average is $10.58. Vicarious Surgical has a 1-year low of $4.27 and a 1-year high of $19.00.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings results on Monday, March 17th. The company reported ($2.43) EPS for the quarter, beating the consensus estimate of ($2.69) by $0.26. The company had revenue of $2.09 million during the quarter. During the same period in the previous year, the company posted ($2.25) earnings per share. On average, equities research analysts anticipate that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RBOT. DnB Asset Management AS increased its stake in Vicarious Surgical by 21.1% during the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after acquiring an additional 3,692 shares during the last quarter. Geode Capital Management LLC increased its stake in Vicarious Surgical by 8.2% during the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after acquiring an additional 2,336 shares during the last quarter. Finally, Renaissance Technologies LLC increased its stake in Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.